MedPath

Acclimatization Mechanisms During Ascent to 7500m

Not Applicable
Completed
Conditions
Acute Mountain Sickness
Interventions
Behavioral: ascent protocol
Registration Number
NCT00603122
Lead Sponsor
University of Zurich
Brief Summary

The trial evaluates the role of ascent protocol on acute mountain sickness and cardio-respiratory physiology during an ascent to Muztagh Ata (7546m). Two groups of mountaineers ascend with different acclimatization time to the summit. The prevalence and severity of symptoms of acute mountain sickness are evaluated along with physiologic variables.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Healthy, physically fit subject
  • Mountaineering experience
Exclusion Criteria
  • Any type of cardiac or respiratory disease
  • Regular intake of any medication
  • History of high altitude pulmonary oedema
  • Severe acute mountain sickness at altitudes below 3500m or high altitude cerebral oedema.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1ascent protocolfast ascent
2ascent protocolslow ascent
Primary Outcome Measures
NameTimeMethod
acute mountain sicknessduring ascent
Secondary Outcome Measures
NameTimeMethod
mountaineering success, oxygen saturation, breathing patternduring ascent
© Copyright 2025. All Rights Reserved by MedPath